Life expectancy with chronic kidney disease: an educational review

• Published in: Pediatric nephrology (Berlin, West) West), 2017-02, Vol.32 (2), p.243-248
• Main Author: Neild, Guy H.
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Age Factors; Age groups; Blood pressure; Cardiovascular disease; Cardiovascular Diseases - complications; Child; Congenital diseases; Creatine - blood; Creatinine; Diagnosis; Educational Review; Female; Glomerular Filtration Rate; Humans; Kidney diseases; Life Expectancy; Male; Medicine; Medicine & Public Health; Nephrology; Patients; Pediatrics; Renal Dialysis - statistics & numerical data; Renal Insufficiency, Chronic - classification; Renal Insufficiency, Chronic - complications; Renal Insufficiency, Chronic - mortality; Renal replacement therapy; Risk Factors; Urology; Young Adult
• ISSN: 0931-041X; 1432-198X
• DOI: 10.1007/s00467-016-3383-8

Can renal prognosis and life expectancy be accurately predicted? Increasingly, the answer is yes. The natural history of different forms of renal disease is becoming clearer; the degree of reduction in glomerular filtration rate (GFR) and the magnitude of proteinuria are strong predictors of renal outcome. Actuarial data on life expectancy from the start of renal replacement therapy are available from renal registries such as the U.S. Renal Data System (USRDS), and the UK Renal Registry. Recently, similar data have become available for patients with chronic kidney disease. Data collected from a large population-based registry in Alberta, Canada and stratified for different levels of estimated GFR (eGFR) have shown that the reduction in life expectancy with kidney failure is not a uremic event associated with starting dialysis but a continuous process that is evident from an eGFR of ≤60 ml/min. Nevertheless, despite the poor prognosis of the last stages of renal failure, progress in the treatment and management of these patients and, in particular, of their cardiovascular risk factors continues to improve long-term outcome.